PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2008 2009
ACTIVITY UNCHANGED FROM COP 2008
1. LIST OF RELATED ACTIVITIES
This activity relates to activities in HIV Treatment: ARV drugs and Laboratory Infrastructure.
2. ACTIVITY DESCRIPTION.
The USAID funded Strengthening Pharmaceutical Systems Project (SPS), implemented by Management
Sciences for Health, will continue to strengthen, improve and maintain the national logistics and distribution
system for HIV clinical care, support and the prevention of TB. Through system strengthening, training and
monitoring, the National Leprosy and Tuberculosis Program (NLTP) will be enabled to improve case
detection rates, establish Diagnostic Counseling and Testing (DTC) and provide integrated TB/HIV
treatment and referral. Under the KEMSA support, SPS will continue supporting Central NTLP and
peripheral NTLP activities and at the same time, develop plans to capacitate NTLP to assume key
administrative and operational activities. As with other MOH programs and services which have continued
to request technical support for quantification and forecasting, the NLTP has also expressed a need in
these areas. Specifically, NLTP would benefit from greater knowledge and skills in quantification and
forecasting so as to move away from annual historical projections for commodities that contribute to
perennial stock outs and/or over supply. In view of the relatively high rate of HIV/TB co-infection a national
level, an integrated approach to HIV commodities procurement and management will be enhanced in order
to provide a fully integrated TB/HIV service at provincial and district level.
2. CONTRIBUTIONS TO OVERALL PROGRAM AREA
This activity will support the distribution and logistics systems for equipment, supplies and training
necessary to implement the National TB program for integrated TB/HIV activities. Targets for patients
treated as a result of these activities are listed under the activities funded through the NLTP and other
partners collaborating in the implementation of integrated TB/HIV activities.
3. LINKS TO OTHER ACTIVITIES
This activity also relates to activities in ARV drugs and Laboratory Infrastructure, which concentrate on
improving logistics for the various HIV/AIDS related commodities.
4. POPULATIONS BEING TARGETED
The main beneficiaries are people living with HIV/AIDS.
5. EMPHASIS AREAS
The major emphasis area for this component is logistics serving to enhance the availability of anti-TB drugs.
Minor areas of emphasis include quality assurance and support supervision and training.
New/Continuing Activity: Continuing Activity
Continuing Activity: 14923
Continued Associated Activity Information
Activity Activity ID USG Agency Prime Partner Mechanism Mechanism ID Mechanism Planned Funds
System ID System ID
14923 8713.08 U.S. Agency for Management 6976 390.08 SPS $600,000
International Sciences for
Development Health
8713 8713.07 U.S. Agency for Management 4260 390.07 RPM/PLUS $1,400,000
Table 3.3.12:
1. LIST OF RELATED ACTIVITIES This activity relates to HLAB and TB/HIV services implemented by
MSH/SPS, the ARV procurement contract to be awarded by USAID through a mission competitive
procurement and HLAB , MTCT and HVCT activities by SCMS.
2. ACTIVITY DESCRIPTION
The USAID funded Strengthening Pharmaceutical Services Project (SPS), implemented by Management
Sciences for Health (MSH) will provide technical assistance in commodity management to KEMSA,
NASCOP and the Department of Pharmaceutical Services to strengthen commodity supply chain systems
supporting ART and other medical and pharmaceutical commodities related to HIV/AIDS. To assist in
capacity building for commodity management, SPS will continue to implement curricula for training ART
healthcare workers at all levels of care. SPS will also strengthen systems by developing and applying
Standard Operating Procedures for commodity management tools. In the 2009 COP implementation period,
SPS will continue to work directly with KEMSA and its staff at the Logistics Management Unit (LMU) in order
to support their activities that were previously supported under the MSH/RPM+ project. This includes
managing the LMIS system of parallel commodities. During COP 2009 period, this database that has been
maintained by MSH/SPS for some time now and has facilitated distribution of reports to relevant divisions
and agencies on stock status, will be transitioned to, mainstreamed and maintained by KEMSA. When this
transition happens, it will entail: expansion of the LMIS database to include all products warehoused and
distributed by KEMSA, finalization of the LMIS user manual, training KEMSA and users from MOH
departments (NASCOP, KEPI, RH, NLTP and essential drug programs) on how to use the LMIS and
implementing facility based forms and tools for recording and summarizing commodity usage data. This
component is part of the continued development of the national medical and pharmaceutical supply chain
system that distributes ARVs and other medical and pharmaceutical commodities from the national
warehouses to district warehouses and points of service. Over 400 points of service - public, private,
mission and NGO are served by this system. SPS will work with key partners to update product selection
according to MOH standard treatment guidelines, verify registration status, quantify requirements and
update forecasts to enable uninterrupted procurement. The LMIS system will enable timely and accurate
collection and reporting of ARV drug and other commodities to the National AIDS and STD Control Program
(NASCOP), KEMSA, the new USAID ARV procurement contractor, divisions of the MOH, and other
partners. These integrated activities will be jointly funded with non-HIV/AIDS funds to support the entire
national procurement and distribution system, with a key emphasis on reliable distribution of HIV/AIDS
commodities down to the "last mile." Key partners with whom SPS will work include: KEMSA, the Kenya
Government organization responsible for procuring and distributing medical supplies to government facilities
and currently responsible for distribution of all pharmaceuticals procured with resources from the
Government of Kenya and the Global Fund, the Supply Chain Management System contract (SCMS), the
major procurement and distribution partner of PEPFAR, and the National AIDS and STD Control Program
(NASCOP), the program with overall responsibility for management of the GOK program. SPS will also work
with the Department of Pharmaceutical Services and its institutions to support the policy and practice reform
agenda aimed at strengthening national skills and capacity in commodity selection, quantification,
procurement, distribution, quality assurance and appropriate use of commodities needed for the treatment
and care of PLWHA. SPS will also support activities by the pharmacy professional associations, the
NGO/private sector aimed at improving access and use of ARVs and other medicines in support of the
national ART programme. These will include implementation of the revised National Drug Policy to include
components supportive of the provision of effective ART commodity management services; preparation of
the national strategic plan to guide the pharmaceutical sub-sector; implementation of the Strategic Plan for
Pharmaceuticals services, support to stakeholders in the development and dissemination of various ART
policy guidelines; and advocacy for linkages between the Department of Pharmaceutical Services,
NASCOP, PPB , KEMSA, NQCL in cross-cutting issues such pharmaco-vigilance, ART drug procurement
and Quality Assurance. At site level, SPS will continue to provide technical assistance in the development
and adaptation of SOPs and forms; use of inventory management tools for patient medication counseling
for adherence; commodity management M&E systems, including Drug Utilization Reviews (DUR); the
design and implementation of ART Drug Management Information Systems; and training and monitoring for
performance improvement at site level employing the MTP methodology.
3. CONTRIBUTIONS TO OVERALL PROGRAM AREA
These activities will support the establishment of a sustainable national supply chain system capable of
managing medical and pharmaceutical supplies right from product selection, registration through
procurement, storage, distribution and consumption reporting, in proportion to the national epidemic.
4. POPULATIONS TARGETTED
The main populations targeted are people living with HIV/AIDS, health workers in the public sector and
MOH policymakers and managers.
The major emphasis area is systems strengthening of the public procurement and supply chain. Minor
emphasis areas are logistics, QA/QI and Training.
Continuing Activity: 14924
14924 4209.08 U.S. Agency for Management 6976 390.08 SPS $4,000,000
6989 4209.07 U.S. Agency for Management 4260 390.07 RPM/PLUS $3,200,000
4209 4209.06 U.S. Agency for Management 3243 390.06 RPM/PLUS $1,800,000
Table 3.3.15:
SECONDARY CROSS-CUTTING BUDGET ATTRIBUTIONS
This activity will support human capacity development through training.
COP 2008
+ Other (NON-SUBSTANTIVE) change will include the following:
MSH will assist in the implementation of the national Lab policy and strategy particularly regarding local
performance standards for labs. In addition MSH will provide support to the local accreditation of peripheral
labs assisting in classifying labs that are suitable to provide support to HIV patients.
This activity is related to the HVTB activity.
2. ACTIVITY DESCRITION
This activity will involve supporting the Ministries of Health through NPHLS and NASCOP to improve quality
management systems through coordination of trainings, work shops and seminars to develop national
policies and improve laboratory practices. Existing laboratory management information systems (MIS) will
be strengthened. Standard Operating Procedures (SOPs) for quality and efficiency of laboratory services
and job aids for Good Laboratory Practices (GLP) will be developed. The management and coordination of
the laboratory network will be strengthened. RPM Plus will provide technical assistance to strengthen
laboratory services in support of ART by working synergistically with the Laboratory ICC and other
stakeholders. All RPM Plus laboratory activities will be conducted under the auspices of the NPHLS. This
includes support for national-level activities such as those mentioned above as well as the implementation
of the national laboratory policy; implementation of a national laboratory policy strategic plan; and
development of institutional capacity by institutionalizing laboratory SOPs. RPM Plus will also support
NPHLS activities aimed at strengthening and scaling up laboratory activities at priority ART sites. Activities
include: refurbishment of priority laboratories (including the proposed Central Microbiology laboratory at the
NPHLS), facilitating training laboratory staff in skills for ART, SOPs and good laboratory practices such as
improved handling, transportation of specimens and return of results as well as universal precautions, and
improved laboratory record keeping and MIS. In addition, this project will assist laboratories by providing
guidance on the ART policy, professional and operational information and materials as needed; developing
SOPs on equipment maintenance, and strengthening sites to implement internal and external quality
assurance procedures. The project will also provide support to laboratory supervisors to strengthen their
management and coordination of laboratory services (supervisory check lists, job aids, monitoring tools,
operational planning guides), and will help institutionalize laboratory quality assurance procedures including
performance of internal quality controls (QCs) and calibration of equipment; training on the laboratory MIS,
monitoring and evaluation (M&E) tools and the use of routine laboratory data. MSH/SPS will closely
collaborate with NASCOP, NPHLS, KEMRI, CDC, KEMSA, UON, AMREF, FHI KMTC, AKMLSO, KMLTTB,
CDC, JSI, Clinton Foundation, USG HIV care and support grantees, private sector organizations and other
stakeholders comprising the National Laboratory Inter-agency Coordinating Committee (ICC).
This activity will result in improving access and use of quality diagnostic laboratory services through
improved training and capacity building, laboratory policies and management, including use of SOPs and
implementation of QA/QC systems.
4. LINKS TO OTHER ACTIVITIES
This activity links to the HVTB activity.
5. POPULATIONS TARGETED
The populations targeted are laboratory technicians at priority Ministry of Health ART centers, and
policymakers and division heads in the MOH.
6. EMPHASIS AREAS The main emphasis area is Training, with minor emphases on Strategic Information
and QA/QI/SS.
Continuing Activity: 14925
14925 4210.08 U.S. Agency for Management 6976 390.08 SPS $900,000
6990 4210.07 U.S. Agency for Management 4260 390.07 RPM/PLUS $1,550,000
4210 4210.06 U.S. Agency for Management 3243 390.06 RPM/PLUS $700,000
Emphasis Areas
Health-related Wraparound Programs
* Child Survival Activities
* Malaria (PMI)
* Safe Motherhood
* TB
Workplace Programs
Human Capacity Development
Estimated amount of funding that is planned for Human Capacity Development $500,000
Public Health Evaluation
Food and Nutrition: Policy, Tools, and Service Delivery
Food and Nutrition: Commodities
Economic Strengthening
Education
Water
Table 3.3.16: